SANDER DALE A. (CFO & CCDO) sold 14.7% of their position (45.89K shares) of HUMACYTE, INC. on the open market
Open‑market sale worth $41.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/20/2026ACC: 0001878193-26-000002
-45.89K
Net shares
Net seller
$41.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
45.89K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−45.89K
Price / share
$0.90
Trade value
$41.15K
% of position
14.7%
5/18/2026
313.10K→267.21K
Total
Net shares
−45.89K
Net value
-$41.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | S · Sale | −45.89K | $0.90 | $41.15K | 14.7% | 313.10K | 267.21K |
| Total | −45.89K | -$41.15K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.60K
Total
40.60K indirect40.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.60K | Indirect |
| Total | 40.60K | 40.60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported